On tonight’s MAD MONEY on CNBC, Jim Cramer said he wanted to review some picks that you might want to own with a 5-year time horizon for the future. He wants to look beyond the current markets and the volatility, so he wants to look at earnings visibility for a multi-year period. So that way he can look past a major market swing or against an analyst panicking over a stock drop. He has three picks that have 5-years worth of visibility and his SECOND PICK is as follows:
Cramer’s second pick for 5-years out tonight was MedcoHealth Solutions, Inc. (NYSE:MHS). Cramer loves the visibility on, and the drops recently allow you to get it cheaper. The pharmacy benefit manager is one of the healthcare cost containment companies and that sector has huge visibility. They even make more when big brand drugs lose their patents, and $77 Billion worth of blockbuster drugs are coming off patent in the coming years. This allows MedcoHealth to pit the drug sellers against each other and it gets to make more off customers than you’d expect. The growth is visible and he thinks there is a $6 Billion gain coming in profits. Cramer also loves its higher margin tailored drug program and its mail order business, but he really loves the visibility to 2012.
Here is our own open email distribution list where we highlight some other Cramer picks, buyouts, break-ups, spin-offs, value stocks, merger-arb, and more.
Jon C. Ogg December 17, 2007
Jon Ogg can be reached at [email protected]; he produces the SPECIAL SITUATION newsletter and he does not own securities in the companies he covers.
Smart Investors Are Quietly Loading Up on These “Dividend Legends”
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats.
There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside.
If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.